Get started
Author

Marco Basiricò

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
2013 · Ymera Pignochino, Carmine Dell'Aglio, et al. · Clinical Cancer Research · 107
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
2017 · Ymera Pignochino, Federica Capozzi, et al. · Molecular Cancer · 72
PDF
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
2020 · Valeria Leuci, Chiara Donini, et al. · Clinical Cancer Research · 48
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody
2018 · Martina Sanlorenzo, Igor Vujic, et al. · Clinical Cancer Research · 47
PDF
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
2015 · Ymera Pignochino, Carmine Dell’Aglio, et al. · BMC Cancer · 38
PDF
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.
2018 · Giulia Mesiano, Giovanni Grignani, et al. · OncoImmunology · 33
PDF
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights
2020 · Giulia Chiabotto, Giovanni Grignani, et al. · Cancers · 31
PDF
Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
2019 · Chiara Varamo, Caterina Peraldo-Neia, et al. · Cancers · 30
PDF
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)
2022 · Pasquale Lombardi, Giacomo Aimar, et al. · Oncology Reports · 19
PDF
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
2022 · Ramona Rotolo, Valeria Leuci, et al. · Clinical Cancer Research · 18
PDF
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
2022 · Erika Fiorino, Alessandra Merlini, et al. · International Journal of Molecular Sciences · 17
PDF
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
2023 · Lidia Giraudo, Giulia Cattaneo, et al. · Journal of Experimental & Clinical Cancer Research · 15
PDF
A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient
2021 · Caterina Peraldo-Neia, Annamaria Massa, et al. · Cancers · 14
PDF
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
2024 · Erica Torchiaro, Marco Cortese, et al. · Journal of Translational Medicine · 13
PDF
Full chimaeric CAR . CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers
2022 · Paola Circosta, Chiara Donini, et al. · British Journal of Haematology · 11
PDF
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study
2021 · Ymera Pignochino, Giovanni Crisafulli, et al. · Cancers · 7
PDF
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
2022 · Annamaria Massa, Caterina Peraldo-Neia, et al. · Frontiers in Oncology · 6
PDF
Off‐label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center
2022 · Rosita Cenna, Marco Basiricò, et al. · Pediatric Blood & Cancer · 5
Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
2025 · Annamaria Massa, Francesca Vita, et al. · Cancers · 4
PDF
Observational studies - The Cinderella of the Italian research system
2023 · Celeste Cagnazzo, Marco Basiricò, et al. · Tumori Journal · 4
PDF
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy
2021 · Marco Carlo Merlano, Andrea Abbona, et al. · Vaccines · 4
PDF
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient
2023 · Erica Torchiaro, Consalvo Petti, et al. · Frontiers in Oncology · 2
European Clinical Trials Regulation 536/2014: Concerns and Perspectives of a Member State
2022 · C. Cagnazzo, R. Cenna, et al. · Annals of Research in Oncology · 2
PDF
Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: Preliminary data from the prospective observational CHECKPOINT trial (NCT02665312)
2019 · P. Lombardi, G. Aimar, et al. · Annals of Oncology · 2
PDF
Supplemental Figure 3 from Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
2023 · Ramona Rotolo, Valeria Leuci, et al. · 1
PDF
Works count: 83
Citation count: 552
H-index: 13
I10-index: 15
Year
Topic
Type